The coronavirus disease 2019 (COVID-19) pandemic has illustrated the vulnerability of patients with chronic kidney disease (CKD) to poor and inequitable clinical outcomes during health care crises.1 Persons with CKD are at increased risk for hospital admissions and critical illness due to COVID-19.2 Disadvantaged populations, including Black and Hispanic individuals and those with low socioeconomic status, are at disproportionate risk for both kidney disease3 and acquiring COVID-19. For example, in a cohort of patients in Louisiana, Black patients were more likely to have CKD and be hospitalized and die from COVID-19.